Furthermore, The PCSK9 inhibitor exerts a protective effect against BLM-induced mouse lung fibrosis and MLE-12 cell injury through modulation of Wnt/β-catenin signaling and ultimately alleviating the development of PF-induced PH. Here, PCSK9 is linked to pulmonary fibrosis.